Hostname: page-component-7dd5485656-c8zdz Total loading time: 0 Render date: 2025-10-30T01:25:13.225Z Has data issue: false hasContentIssue false
  • English
  • Français

Patterns of hypnotic drug prescription in Italy

A two-week community survey

Published online by Cambridge University Press:  03 January 2018

M. Balestrieri ,
M. Bortolomasi ,
M. Galletta  and
C. Bellantuono
M. Balestrieri*
Affiliation:
Dipartimento di Patologia e Medicina SC, University of Udine, Udine
M. Bortolomasi
Affiliation:
Istituto di Psichiatria, University of Verona, Verona, Italy
M. Galletta
Affiliation:
Istituto di Psichiatria, University of Verona, Verona, Italy
C. Bellantuono
Affiliation:
Istituto di Psichiatria, University of Verona, Verona, Italy
*
Professor M. Balestrieri, Servizio di Psicologia Medica, Ospedale Policlinico, 37134 Verona, Italy
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

In Italy a number of studies have been published on psychotropic drug use in general practice and community settings. However, the present study is the first Italian study to focus on hypnotic drug prescriptions in a large community sample.

Method

Data were collected from 145 of the total of 404 pharmacies of five large cities in north-eastern Italy. All consecutive patients presenting a prescription for a hypnotic drug were interviewed by the pharmacists during a two-week period.

Results

The pharmacists interviewed 7/44 consecutive patients. The highest prevalence of prescriptions for hypnotic drugs was found in the elderly and in women. The majority (96%) of prescriptions were for benzodiazepines, with lorazepam and triazolam accounting for 50%. Short-acting and ultra-short-acting benzodiazepines were more frequently prescribed for sleep induction by general practitioners (GPs) than by psychiatrists and other physicians. Frequently the benzodiazepine used as a hypnotic was also prescribed for day time sedation. Approximately 72% of subjects reported they had been taking the prescribed drug for one year or more.

Conclusions

In Italy benzodiazepines are the most frequently prescribed drugs for sleep induction; as they are widely prescribed for elderly people by GPs often for long periods of time, educational programmes and guidelines on the rational use of benzodiazepines in general practice are needed.

Information

Type
Papers
Information
The British Journal of Psychiatry , Volume 170 , Issue 2 , February 1997 , pp. 176 - 180
Copyright
Copyright © 1997 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Ashton, C. H. (1994) Guidelines for the rational use of benzodiazepines. When and what to use. Drugs, 48, 25–40.Google Scholar
Balter, M. B. & Uhlenhuth, E. H. (1991) The beneficial and adverse effects of hypnotics, Journal of Clinical Psychiatry, 52 (suppl. 7), 16–23.Google Scholar
Bellantuono, C., Williams, P. & Tansella, M. (1991) Psychiatric morbidity in general practice. In Community-Based Psychiatry: Long-Term Patterns of Care in South-Verona (ed. Tansella, M.). pp. 141–145. Psychological Medicine. Monograph Supplement 19. Cambridge: Cambridge University Press.Google Scholar
Dunbar, G. C., Perara, M. H. & Jenner, F. A. (1989) Patterns of benzodiazepine use in Great Bntain as measured by a general population survey British Journal of Psychiatry, 155, 836–841.Google Scholar
Griffiths, R. R. (1995) Commentary on review by Woods and Winger Benzodiazepines: long-term use among patients is a concern and abuse among polydrug abusers is not trivial. Psychopharmacology, 118, 116–117.Google Scholar
Johnston, L. D., O'Mailley, P. M. & Bachman, J. G. (1991) National Survey Results on Drug Use from the Monitoring the Future Study, 1975–1992, NIH Publication nos 93–3597 & 93–3598. Washington. DC: US Government Printing Office.Google Scholar
Jonas, J. M., Coleman, B. S., Sherdan, A. Q. et al (1992) Comparative clinical profiles of triazolam versus other shorter-acting hypnotics, Journal of Clinical Psychiatry, 53 (suppl. 12). 19–31.Google Scholar
Klett, C. J. (1992) Review of triazolam data. Journal of Clinical Psychiatry, 53 (suppl. 12) 61–67.Google Scholar
Ladar, M. (1995) Connmentary on review by Woods and Winger Psychopharmacology, 118, 118.Google Scholar
Lugaresi, E., Cirignotta, F., Zucconi, M., et al (1983) Good and poor sleepers: An epidemiological survey of the San Marino population. In Sleep/Woke Disorders: Natural History Epidemiology and Long-Term Evolution (eds Guilleminault, C. & Lugaresi, E.), pp 1–12. New York: Raven Press.Google Scholar
Nolan, L. & O'Malley, K. (1988) Patients, prescribing and benzodiazepines. Journal of Clinical Psychopharmacology, 35, 225–229.Google Scholar
North, D. A., McAroy, B. R. & Powell, A. M. (1992) Benzodiazepine use in general practice – is it a problem? New Zealand Medical Journal, 105, 287–289.Google Scholar
Olfson, M. & Klerman, G. L. (1993) Trends in the prescription of psychotropic medications. Medical Care, 31, 559–564.Google Scholar
Olfson, M., Klerman, G. L. & Pincus, H. A. (1994) Use of benzodiazepines in the community. Archives of Internal Medicine, 154, 1235–1240.Google Scholar
Payne, C. D. (ed.) (1986) The GLIM System Release 3.77 Manual. Generalised Interactive Modelling, London: Royal Statistical Society.Google Scholar
Piccinelli, M., Pini, S., Bonlzzato, P., et al (1995) Results from the Verona Centre. In Mental Illness in General Health Care. An International Study (eds Ustun, T. B. & Sartorius, N.). pp 301–321. Chichester: Wiley.Google Scholar
Shader, R. I. & Greenblatt, D. J. (1991) Use of benzodiazepines in anxiety disorders. New England Journal of Medicine, 32A, 1398–1405.Google Scholar
Üstün, T. B. & Sartorius, N. (eds) (1995) Mental Illness in General Health Care. An International Study Chichester: Wiley.Google Scholar
Woods, J. H. & Winger, G. (1995) Current benzodiazepine issues. Psychopharmacology, 118, 107–115.Google Scholar
Wysowski, D. K. & Barash, D. (1991) Adverse behavioural reactions to triazolam in the Food and Drug Administrations Spontaneous Reporting System. Archives of Intemal Medicine, 151, 2003–2008.Google Scholar
Wysowski, D. K., Barash, D. & Baum, C. (1991) Outpatient use of prescription sedative-hypnotic drugs in the United States. 1980 through 1989 Archives of Intemal Medicine, 151, 1779–1783.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.